The company said it completed about 54,000 Cologuard tests in Q2, and that the cumulative number of physicians ordering the test since its launch has risen to 41,000.
The firm plans to use the funds to support ongoing clinical trials, as well as development and commercialization of its full range of tests.
Last month, the foundation, in partnership with the Washington State Department of Health, released seven educational videos about prenatal testing.
The agency has doubled the window after suspected exposure during which it recommends RT-qPCR testing for some pregnant women.
Clinical lab supply firm Streck will exclusively supply Biodesix with DNA and RNA tubes, including its lines of blood collection tubes.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.
Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.
A new report indicates that women are underrepresented among US patent holders.